Investigation of cardiac status and bone mineral density in Turner syndrome

Growth Hormone and IGF Research

Volumn 16, Issue SUPPL., 2006, Pages 103-108

  Bondy, Carolyn A ^a   Bakalov, Vladimir K ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Congenital heart defects; Magnetic resonance angiography; Osteoporosis; SHOX; X chromosome

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; GADOLINIUM; GLUCOCORTICOID; RECOMBINANT GROWTH HORMONE; VITAMIN D;

AORTA ANEURYSM; AORTA DISSECTION; AORTA VALVE DISEASE; ARTICLE; BONE DENSITY; BONE MALFORMATION; BONE MINERALIZATION; COMPRESSION FRACTURE; CONGENITAL HEART DISEASE; CORTICAL BONE; DENSITOMETRY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FRACTURE; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MONOSOMY X; OSTEOPENIA; OSTEOPOROSIS; PATIENT MONITORING; PREMATURE OVARIAN FAILURE; PREPUBERTY; PREVALENCE; PRIORITY JOURNAL; PULMONARY VEIN MALFORMATION; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; TRABECULAR BONE; TURNER SYNDROME; VARICOSIS;

BONE DENSITY; FEMALE; HEART; HEART DISEASES; HUMANS; OSTEOPOROSIS; TURNER SYNDROME;

EID: 33745477469     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.03.008     Document Type: Article

References (42)

1. Nielsen J., and Wohlert M. Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig. Artic. Ser. 26 (1990) 209-223
2. Nielsen J., and Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum. Genet. 87 (1991) 81-83
3. Gravholt C.H., Juul S., Naeraa R.W., and Hansen J. Prenatal and postnatal prevalence of Turner's syndrome: a registry study. Br. Med. J. 312 (1996) 16-21
4. Jacobs P.A., Melville M., Ratcliffe S., Keay A.J., and Syme J. A cytogenetic survey of 11,680 newborn infants. Ann. Hum. Genet. 37 (1974) 359-376
5. Lippe B. Turner syndrome. Endocrinol. Metab. Clin. North Am. 20 (1991) 121-152
6. Sybert V.P., and McCauley E. Turner's syndrome. N. Engl. J. Med. 351 (2004) 1227-1238
7. Nijhuis-van der Sanden M.W., Eling P.A., and Otten B.J. A review of neuropsychological and motor studies in Turner syndrome. Neurosci. Biobehav. Rev. 27 (2003) 329-338
8. Ross J., Zinn A., and McCauley E. Neurodevelopmental and psychosocial aspects of Turner syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 6 (2000) 135-141
9. Saenger P., Wikland K.A., Conway G.S., et al. Recommendations for the diagnosis and management of Turner syndrome. J. Clin. Endocrinol. Metab. 86 (2001) 3061-3069
10. Dawson-Falk K.L., Wright A.M., Bakker B., Pitlick P.T., Wilson D.M., and Rosenfeld R.G. Cardiovascular evaluation in Turner syndrome: utility of MR imaging. Australas. Radiol. 36 (1992) 204-209
11. Ho V.B., Bakalov V.K., Cooley M., et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110 (2004) 1694-1700
12. Bechtold S.M., Dalla Pozza R., Becker A., Meidert A., Dohlemann C., and Schwarz H.P. Partial anomalous pulmonary vein connection: an underestimated cardiovascular defect in Ullrich-Turner syndrome. Eur. J. Pediatr. 163 (2004) 158-162
13. Ostberg J.E., Brookes J.A.S., McCarthy C., Halcox J., and Conway G.S. A comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome. J. Clin. Endocrinol. Metab. 89 (2004) 5966-5971
14. Prandstraller D., Mazzanti L., Picchio F., et al. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 nonpreselected patients. Pediatr. Cardiol. 20 (1999) 108-112
15. Sybert V.P. Cardiovascular malformations and complications in Turner syndrome. Pediatrics 101 (1998) e11
16. Price W.H., Clayton J.F., Collyer S., De Mey R., and Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J. Epidemiol. Commun. Health 40 (1986) 97-102
17. Lin A.E., Lippe B., and Rosenfeld R.G. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 102 (1998) e12
18. Elsheikh M., Casadei B., Conway G.S., and Wass J.A. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin. Endocrinol. (Oxf.) 54 (2001) 69-73
19. Bondy C.A., Van P.K., Bakalov V.K., Ho V.B., Sachdev V., and Rosing D.R. Prolongation of the QTc interval in Turner syndrome. Medicine 85 (2006) 1-7
20. Robbins J., Nelson J.C., Rautaharju P.M., and Gottdiener J.S. The association between the length of the QT interval and mortality in the Cardiovascular Health Study. Am. J. Med. 115 (2003) 689-694
21. Montanez A., Ruskin J.N., Hebert P.R., Lamas G.A., and Hennekens C.H. Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch. Intern. Med. 164 (2004) 943-948
22. Blair J., Taggart B., and Martin A. Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology. J. Neural Transm. 111 (2004) 791-815
23. Bakalov V., Chen M., Baron J., et al. Bone mineral density and fractures in Turner syndrome. Am. J. Med. 115 (2003) 257-262
24. Jobe S., Donohoue P., and Di Paola J. Deep venous thrombosis and Turner syndrome. J. Pediatr. Hematol. Oncol. 26 (2004) 272
25. Hanton L., Axelrod L., Bakalov V., and Bondy C.A. The importance of estrogen replacement in young women with Turner syndrome. J. Womens Health (Larchmt.) 12 (2003) 971-977
26. Gravholt C.H., Lauridsen A.L., Brixen K., Mosekilde L., Heickendorff L., and Christiansen J.S. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study. J. Clin. Endocrinol. Metab. 87 (2002) 2798-2808
27. Bechtold S., Rauch F., Noelle V., et al. Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J. Clin. Endocrinol. Metab. 86 (2001) 5819-5823
28. Dalla Palma L., and Cavina C. Turner's syndrome: radiological appearances. Radiol. Clin. Biol. 35 (1966) 65-79
29. Hogler W., Briody J., Moore B., Garnett S., Lu P.W., and Cowell C.T. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J. Clin. Endocrinol. Metab. 89 (2004) 193-199
30. Rao E., Weiss B., Fukami M., et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat. Genet. 16 (1997) 54-63
31. Ogata T. SHOX: pseudoautosomal homeobox containing gene for short stature and dyschondrosteosis. Growth Horm. IGF Res. 9 Suppl. B (1999) 53-57 Discussion 57-58
32. Ross J.L., Scott Jr. C., Marttila P., et al. Phenotypes associated with SHOX deficiency. J. Clin. Endocrinol. Metab. 86 (2001) 5674-5680
33. Gravholt C.H., Vestergaard P., Hermann A.P., Mosekilde L., Brixen K., and Christiansen J.S. Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey. Clin. Endocrinol. (Oxf.) 59 (2003) 89-96
34. Cosman F., Nieves J., Zion M., Woelfert L., Luckey M., and Lindsay R. Daily and cyclic parathyroid hormone in women receiving alendronate. N. Engl. J. Med. 353 (2005) 566-575
35. Sas T.C., de Muinck Keizer-Schrama S.M., Stijnen T., et al. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr. Res. 50 (2001) 417-422
36. Neely E.K., Marcus R., Rosenfeld R.G., and Bachrach L.K. Turner syndrome adolescents receiving growth hormone are not osteopenic. J. Clin. Endocrinol. Metab. 76 (1993) 861-866
37. Shaw N.J., Rehan V.K., Husain S., Marshall T., and Smith C.S. Bone mineral density in Turner's syndrome - a longitudinal study. Clin. Endocrinol. (Oxf.) 47 (1997) 367-370
38. Carrascosa A., Gussinye M., Terradas P., Yeste D., Audi L., and Vicens-Calvet E. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J. Bone Miner. Res. 15 (2000) 2005-2010
39. Suganuma N., Furuhashi M., Hirooka T., et al. Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr. J. 50 (2003) 263-269
40. Bakalov V.K., Axelrod L., Baron J., et al. Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J. Clin. Endocrinol. Metab. 88 (2003) 5717-5722
41. Bakalov V.K., Van P.L., Baron J., Reynolds J.C., and Bondy C.A. Growth hormone therapy and bone mineral density in Turner syndrome. J. Clin. Endocrinol. Metab. 89 (2004) 4886-4889
42. Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., and Pak C.Y.C. Severely suppressed bone turnover: a potential complication of alendronate therapy. J. Clin. Endocrinol. Metab. 90 (2005) 1294-1301